US Patent

US10918616 — Fumarate ester pharmaceutical compositions

Method of Use · Assigned to Banner Life Sciences LLC · Expires 2035-02-27 · 9y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical compositions containing fumarate esters and methods for making and using them to treat subjects.

USPTO Abstract

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral pharmaceutical compositions comprising fumarate esters are described.

Drugs covered by this patent

monomethyl-fumarate (MONOMETHYL FUMARATE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1384`	—	monomethyl-fumarate

Patent Metadata

Patent number: US10918616
Jurisdiction: US
Classification: Method of Use
Expires: 2035-02-27
Drug substance claim: No
Drug product claim: No
Assignee: Banner Life Sciences LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.